Senate Panel Approves Declassifying Part of Landmark Report on US Treatment

Senate Panel Approves Declassifying Part of Landmark Report on US Treatment … Senate Panel Approves Declassifying Part of Landmark Report on US Treatment of Terror Suspects. WASHINGTON April 3, 2014 (AP). Associated Press. Senate panel approves declassifying part of landmark… Continue Reading

Insmed Announces Results from Phase 2 Clinical Trial for Treatment Resistant

Insmed Announces Results from Phase 2 Clinical Trial for Treatment Resistant … The randomized, double-blind, placebo-controlled phase 2 clinical trial compared ARIKAYCE (590 mg delivered once daily), added to standard of care treatment, versus standard of care treatment plus placebo,… Continue Reading